Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$160.7B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 0.86%
Avg Daily Range (30 D):	$0.99 | 0.96%
Avg Daily Range (90 D):	$1.04 | 0.93%

Institutional Daily Volume
Avg Daily Volume:	5.67M
Avg Daily Volume (30 D):	8.68M
Avg Daily Volume (90 D):	7.9M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	101,694
Avg Institutional Trade:	$5.75M
Avg Institutional Trade (30 D):	$18.02M
Avg Institutional Trade (90 D):	$15.1M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	17

Market Closing Trades
Avg Closing Trade:	$54.11M
Avg Closing Trade (30 D):	$240.58M
Avg Closing Trade (90 D):	$186.46M
Avg Closing Volume:	654.18K

News

Apr 22, 2026 @ 2:00 PM Coagulation Analyzer Market Size to Reach a Valuat... Source: Sns Insider

Apr 20, 2026 @ 8:21 PM Better Medical Device Stock Right Now: Abbott Labo... Source: Prosper Junior Bakiny

Apr 20, 2026 @ 9:08 AM Market Crash: 2 Healthcare Stocks Worth Loading Up... Source: Adria Cimino

Apr 17, 2026 @ 4:00 PM China Diabetes Devices Market Forecast and Company... Source: Researchandmarkets.Com

Apr 17, 2026 @ 3:17 PM Abbott Stock Crash: Rebound Could Be Coming Fast Source: Thomas Hughes

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.73		$3.73
Diluted EPS	$3.72		$3.72
Revenue	$44.33B		$44.33B
Gross Profit	$25.01B		$25.01B
Net Income / Loss	$6.52B		$6.52B
Operating Income / Loss	$8.05B		$8.05B
Cost of Revenue	$19.32B		$19.32B
Net Cash Flow	$835M		$835M
PE Ratio